Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 232.00
Bid: 231.00
Ask: 232.50
Change: 0.50 (0.22%)
Spread: 1.50 (0.649%)
Open: 238.50
High: 238.50
Low: 230.00
Prev. Close: 231.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Peel Hunt picks 'doublers' for the next 2-3 years

Tue, 18th Dec 2018 11:09

(Sharecast News) - Peel Hunt has named 29 companies it believes will double in value in the next two to three years, including JD Sports, GoCompare and CMC Markets.In "Stock Ideas for 2019: Doublers", published on Tuesday, Peel Hunt conceded it was difficult to predict how Brexit will affect markets, and noted that the FTSE All Share was on track to record its worst annual performance this year since 2008.But it added: "There are always some stocks that are dancing to their own particular tune which could deliver some healthy returns."Peel Hunt has given spread betting firm CMC Markets, which has seen profitability hit by tighter regulations and lower volatility, a price target of 200p."We are confident CMC will ultimately benefit from the impending market consolidation, expansion of the ANZ deal and return of market volatility," it argued. "Relatively small moves should result in significant operating leverage." A target price of 200p is double the last closing price of 100p.It called GoCompare, the price comparison website, a "great stock to help savings", arguing: "The share price has halved since the summer as the market has become unsettled at the near-term revenue trend and the launch of the innovative Saving as a Service product Weflip. "This ignores the profit protection achieved by the improvement in marketing margin and the strong operating cash generation." The price target is 140p, against Monday's close of 69p.Despite the wider retail sector's bumpy performance, JD Sports is one of Peel Hunt's preferred stocks. "It ticks all the boxes: it is growing strongly and winning share in its core market and that is true both online and in store." Peel Hunt also pointed to an "aggressive" overseas expansion."JD has a strong record of delivering and bettering expectations and despite the conditions in the UK, we think that forecasts are at worse underpinned." It added that the current multiple of 11 x PE was "way too low" and the target price is 550p not quite double the latest close.Another retailer to get the nod was Joules. "Against the background of retail turmoil and profit warnings, Joules recently reported first-half group revenue growth of 17.6% with profits tracking slightly ahead of expectations." Peel Hunt is targeting a share price of 400p, against Monday's close of 210p.Clinical stage biopharmaceutical company Motif Bio could see its share price surge early next year, argued Peel Hunt, with the US Food and Drug Administration due to give possible approval to Motif's antibiotic iclaprim on 13 February. Currently trading at 26p, Peel Hunt is targeting a price of 95p.Another healthcare company is PureTech Health, which Peel Hunt argued was "very undervalued" despite being well capitalised. The shares currently trade at 178p but Peel Hunt is looking for 313p.At Ten Entertainment, owner of bowling allies, Peel Hunt is forecasting earnings will rise by more than 50% over the next three years - although it conceded there was an "upside risk to expansion, like-for-like sales and margin forecasts".Peel Hunt said of The AA: "While there are a number of routes that may lead to the share price doubling, the common feature is the delivery of current consensus expectations."Early progress has been encouraging and further reassurance at the pre-close will be a key catalyst."Nanoco was a tech pick, as its new facility to make cadmium-free quantum dots and nanomaterials for its large US customer should be completed by the end of 2018, with volume production expected in the first half of 2019."This should be transformative for the company given the rapid growth in the sensor market," said Peel Hunt's analysts, with industry forecasts is for the 3D imaging & sensing market to increase from $2bn in 2017 to close to $10bn in 2020 and over $18bn by 2023, as Gartner calculated that around 40% of smartphones will have 3D sensors by 2021. The target price is 67p.Other companies highlighted by Peel Hunt included Eland Oil and Gas, Kaz Minerals, Manx Telecom, Polar Capital and Renold.
More News
16 Oct 2019 13:42

FTSE 250 movers: PureTech falls, Mediclinic climbs

(Sharecast News) - London's FTSE 250 was 0.31% lower at 19,134.998 in afternoon trade on Wednesday, as PureTech Health led the index lower.

Read more
4 Oct 2019 18:08

Jupiter UK Growth Assets Fall On Thomas Cook Pain; Remains Upbeat

Jupiter UK Growth Assets Fall On Thomas Cook Pain; Remains Upbeat

Read more
2 Oct 2019 17:35

PureTech Health Takes Final 10% Stake In Ariya Therapeutics

PureTech Health Takes Final 10% Stake In Ariya Therapeutics

Read more
2 Oct 2019 08:12

PureTech secures remaining 10% of Ariya Therapeutics

(Sharecast News) - PureTech Health on Wednesday acquired the remaining 10% of Ariya Therapeutics, with the now wholly-owned subsidiary set to be renamed as PureTech LYT.

Read more
9 Sep 2019 13:04

PureTech Chair Ito Resigns Amid MIT Media Lab Epstein Funding Scandal

(Alliance News) - PureTech Health PLC said Monday Chair Joichi Ito stepped down from the company amid "circumstances related to the MIT Media Lab", with Non-Executive Director Viehbacher

Read more
20 Aug 2019 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 21 August Charter Court Financial ServicesHalf Year ResultsOnesavings Year Year Year 22

Read more
17 Jul 2019 11:47

PureTech Health Acquires LYT-100 Product Candidate To Treat Lymphedema

(Alliance News) - PureTech Health PLC on Wednesday said it has acquired LYT-100 for the potential treatment of lymphatic and immunofibrotic diseases.LYT-100 was acquired from an undisclosed

Read more
11 Jul 2019 08:18

PureTech Health Mulling Listing ADSs On Nasdaq Alongside London

(Alliance News) - PureTech Health PLC is exploring a listing of American depositary shares on the Nasdaq exchange in New York, it said Thursday, which would be backed up by an offering of new a on

Read more
9 Jul 2019 12:55

PureTech Health Receives US Patent For Immuno-Oncology Candidate

(Alliance News) - PureTech Health PLC said Tuesday the US Patent & Trademark Office has issued a patent covering the company's internal immuno-oncology product candidate, said the patent a

Read more
3 Jul 2019 12:48

PureTech Health's Karuna Raises USD103 Million In US IPO

(Alliance News) - PureTech Health PLC said Wednesday that affiliate Karuna Therapeutics Inc has raised USD102.6 million in its initial public offering on the Nasdaq Global Market.PureTech a

Read more
28 Jun 2019 13:23

PureTech Health Investee Karuna Therapeutics Joins Nasdaq

(Alliance News) - PureTech Health PLC affiliate Karuna Therapeutics Inc is to raise nearly USD90 million in its listing on the Nasdaq, PureTech said Friday.Karuna will offer 5.6 million new

Read more
13 Jun 2019 15:19

Positive Results From PureTech Affiliate Male Pattern Hair Loss Study

(Alliance News) - PureTech Health PLC on Thursday said its Follica affiliate is planning a pivotal study after positive data in patients with male pattern hair loss.Shares in company were a

Read more
3 Jun 2019 14:19

PureTech Health Affiliate Karuna To List On Nasdaq (ALLIPO)

LONDON (Alliance News) - PureTech Health PLC on Monday said that its affiliate, Karuna Therapeutics Inc, has filed a public registration statement with the US Securities & Exchange Commission

Read more
22 May 2019 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 23 MayGoCompare.comIntertekInstemAlliance InternationalJKX

Read more
20 May 2019 11:24

Encouraging GS500 Prototype Study By PureTech Affiliate Gelesis

LONDON (Alliance News) - Biopharmaceutical firm PureTech Health PLC on Monday said its Gelesis affiliate has announced "promising clinical data" from a study of a GS500 prototype in has

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.